Skip to main content
Shandong Linuo Pharmaceutical Packaging Co.,Ltd. logo

Shandong Linuo Pharmaceutical Packaging Co.,Ltd. — Investor Relations & Filings

Ticker · 301188 ISIN · CNE100004YW1 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 902 across all filing types
Latest filing 2026-05-13 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 301188

About Shandong Linuo Pharmaceutical Packaging Co.,Ltd.

https://www.linuoglass.com

Shandong Linuo Pharmaceutical Packaging Co., Ltd. specializes in the research, development, and manufacturing of high-quality pharmaceutical glass packaging solutions. The company’s core product portfolio includes neutral borosilicate glass tubes, molded and tubular glass vials, ampoules, and pre-fillable syringes. These products are engineered to provide superior chemical resistance, thermal stability, and low extractables, making them suitable for the storage of injectable medications, vaccines, and sensitive biotechnological products. Utilizing advanced automated production lines and rigorous quality control systems, the company ensures compliance with international standards such as ISO and Good Manufacturing Practice (GMP). Its technical capabilities focus on high-precision glass forming and surface treatment technologies to meet the demanding requirements of global pharmaceutical manufacturers and healthcare providers.

Recent filings

Filing Released Lang Actions
北京市中伦律师事务所关于山东力诺医药包装股份有限公司2025年年度股东会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 80% confidence The document is a formal legal opinion (“法律意见书”) issued by Zhong Lun Law Firm concerning the 2025 annual general meeting of Shandong Linuo Pharma Packaging Co., Ltd. It reviews the AGM’s convening procedures, attendance, and explicitly provides detailed vote counts and resolutions passed at the meeting. This aligns with our “Declaration of Voting Results & Voting Rights Announcements” category, which covers official results from shareholder votes at an AGM or EGM.
2026-05-13 Chinese
2025年年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 90% confidence The document is an official announcement of the resolutions and voting outcomes from the company’s 2025 Annual General Meeting of shareholders, detailing each proposal passed and vote tallies. This matches the definition of a Declaration of Voting Results & Voting Rights Announcement.
2026-05-13 Chinese
2025年度独立董事述职报告（刘媛）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Work Report for 2025" from 山东力诺医药包装股份有限公司. It details the independent director's background, attendance at board and shareholder meetings, committee work, oversight of company governance, review of financial reports, and other duties performed during the year 2025. The content is a detailed narrative of the independent director's activities and assessments rather than a financial report or announcement. It does not contain financial statements or earnings data, nor is it a proxy solicitation or voting result announcement. It is a formal report on the independent director's duties and observations, which fits best under Board/Management Information (MANG) as it relates to management and board-level disclosures about governance and director activities. The document length (5783 characters) and detailed content confirm it is a substantive report, not a brief announcement or certification. Therefore, the classification is MANG with high confidence.
2026-04-22 Chinese
关于举办2025年度业绩说明会的公告
Investor Presentation Classification · 95% confidence The document is an announcement about the scheduling and details of a 2025 annual performance explanation meeting (业绩说明会) to be held on May 15, 2026. It references that the full 2025 Annual Report has already been disclosed on April 23, 2026, and this meeting is intended to provide further communication and answer investor questions. The document is short (1160 characters) and serves as a notice for an upcoming investor event rather than the report itself. It does not contain financial statements or substantive financial data. Therefore, it is best classified as an Investor Presentation (IP) since it is about a detailed presentation for investors focusing on financials and company strategy, not the Annual Report itself or a simple announcement of report publication (RPA).
2026-04-22 Chinese
力诺药包2025年度内部控制审计报告
Audit Report / Information Classification · 95% confidence The document is titled '内部控制审计报告' which translates to 'Internal Control Audit Report'. It includes an audit opinion on the effectiveness of internal control over financial reporting for the fiscal year ending December 31, 2025. The document contains detailed auditor responsibilities, company responsibilities, and audit conclusions. It also includes copies of the auditor's practice certificate, business license, and CPA certificates, which are typical attachments to an audit report. The document length is 2578 characters, which is relatively short but contains substantive audit content rather than just an announcement or certification. Therefore, this is a standalone audit report focused on internal control over financial reporting, fitting the category of Audit Report / Information (AR).
2026-04-22 Chinese
第四届董事会独立董事2026年第三次专门会议审核意见
Board/Management Information Classification · 95% confidence The document is a detailed independent directors' review and opinions on various company matters including the 2025 fundraising usage report, internal control evaluation report, profit distribution plan, remuneration plans, credit facility applications, auditor reappointment, related party transaction limits, stock incentive plan adjustments, and authorization for simplified stock issuance. It references specific reports (e.g., fundraising usage report, internal control evaluation report) but does not contain the full reports themselves. Instead, it provides audit opinions and approvals related to these reports and company governance matters. The document is not a full annual or interim report, nor is it a simple announcement. It is a formal board/management related document focused on governance and approvals by independent directors. Therefore, the best fitting category is Board/Management Information (MANG). The document length (2828 characters) and content support this classification with high confidence.
2026-04-22 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.